Regulation by innate immune T lymphocytes in the host defense against pulmonary infection with Cryptococcus neoformans

被引:0
|
作者
Kawakami, K
机构
[1] Univ Ryukyus, Grad Sch, Dept Internal Med, Div Infect Dis, Okinawa 9030215, Japan
[2] Univ Ryukyus, Fac Med, Okinawa 9030215, Japan
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Recently, innate immune lymphocytes, such as natural killer (NK) T cells and gammadelta antigen receptor-bearing T (gammadelta T) cells, have garnered much attention, and their biological significance in the tumor immunity, allergic diseases and infectious diseases is extensively exploited. We have addressed the role of these cells in the host defense using a mouse model of pulmonary infection with Cryptococcus neoformans, which frequently causes fatal meningoencephalitis in AIDS patients. Host defense to this fungal pathogen is largely mediated by cellular immunity, and type-1 helper T (Th1) cells play a central role in this process. This infection causes a prompt accumulation of both NKT and gammadelta T cells in the lung tissues in a monocyte chemoattractant protein (MCP)-1-dependent or -independent manner, respectively. Genetic deletion of Valpha14+ NKT cells ameliorates the Th1 response and clearance of microorganisms in the lungs, whereas these host protective responses are rather enhanced in mice lacking gammadelta T cells. Thus, in some aspect, these innate immune lymphocytes may co-regulate the Th1-mediated response for induction of the moderate host defense. gammadelta T cells may act to keep the balance of Th1-Th2 responses in a proper manner by suppressing the exaggerated Th1 response caused by NKT cells. In this review, I describe the recent research development in the innate immune host defense against cryptococcal infection in respiratory organs with emphasis on our data in the regulatory role of NKT cells and gammadelta T cells.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 50 条
  • [41] Innate Immune Pathways in Host Defense
    Kanneganti, Thirumala-Devi
    Lamkanfi, Mohamed
    Amer, Amal O.
    MEDIATORS OF INFLAMMATION, 2012, 2012
  • [42] Leukocyte recruitment during pulmonary Cryptococcus neoformans infection
    Huffnagle, GB
    Traynor, TR
    McDonald, RA
    Olszewski, MA
    Lindell, DM
    Herring, AC
    Toews, GB
    IMMUNOPHARMACOLOGY, 2000, 48 (03): : 231 - 236
  • [43] Pulmonary infection with Cryptococcus neoformans in the face of underlying sarcoidosis
    Boyton, Rosemary J.
    Altmann, Daniel M.
    Wright, Andrew
    Kon, Onn Min
    RESPIRATION, 2007, 74 (04) : 462 - 466
  • [44] DEPLETION OF CD4+ (L3T4+) LYMPHOCYTES INVIVO IMPAIRS MURINE HOST DEFENSE TO CRYPTOCOCCUS-NEOFORMANS
    MODY, CH
    LIPSCOMB, MF
    STREET, NE
    TOEWS, GB
    JOURNAL OF IMMUNOLOGY, 1990, 144 (04): : 1472 - 1477
  • [45] Innate immunity and pulmonary host defense
    Zhang, P
    Summer, WR
    Bagby, GJ
    Nelson, S
    IMMUNOLOGICAL REVIEWS, 2000, 173 : 39 - 51
  • [46] Warfare and defense: The host response to Cryptococcus infection
    Dutra, Fabianno F.
    Albuquerque, Priscila C.
    Rodrigues, Marcio L.
    Fonseca, Fernanda L.
    FUNGAL BIOLOGY REVIEWS, 2018, 32 (02) : 35 - 51
  • [47] A T CELL-INDEPENDENT PROTECTIVE HOST RESPONSE AGAINST CRYPTOCOCCUS-NEOFORMANS EXPRESSED AT THE PRIMARY SITE OF INFECTION IN THE LUNG
    HILL, JO
    DUNN, PL
    INFECTION AND IMMUNITY, 1993, 61 (12) : 5302 - 5308
  • [48] Roles of T lymphocytes in defense against experimental acute pulmonary infection of mice with murine cytomegalovirus
    Kimura, G
    Takimoto, H
    Yoshida, H
    Ninomiya, T
    Chen, QJ
    Ohtsu, M
    Nomoto, K
    BIOMEDICAL RESEARCH-TOKYO, 2000, 21 (05): : 225 - 246
  • [49] The role of lymphocytes Tγδ in the immune defense against Plasmodium falciparum
    Carrio, Baptiste
    M S-MEDECINE SCIENCES, 2020, 36 (8-9): : 818 - 819
  • [50] Rapidly enlarging pulmonary mass due to immune reconstitution inflammatory syndrome (IRIS) in an immunocompetent host with pulmonary Cryptococcus neoformans
    Tucker, Mollie
    Sheikh, Abdul Majeed
    Villanueva, Merceditas S.
    BMJ CASE REPORTS, 2022, 15 (03)